PIERCE GLENN
SEC CIK 1256964 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VYGR | Voyager Therapeutics, Inc. | Interim CSO, Dir | 16.8K | — | $63.7K | 2 | 2022-01-13 | 2022-07-14 |
Most active insiders at VYGR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sandrock Alfred | Pres, CEO, Dir | — | $184.4K |
| 2 | Swartz Robin | COO, CBO | — | $55.3K |
| 3 | Jorgensen Nathan D. | CFO | — | $54.2K |
| 4 | Carter Todd Alfred | CSO | — | $40.6K |
| 5 | Shiferman Gregory L. | SVP, GC | — | — |
| 6 | Ferguson Toby | Chief Medical Off | — | — |
PIERCE GLENN made no open-market trades at VYGR in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-18 | 2022-07-14 | VYGR | Voyager Therapeutics, Inc. | PIERCE GLENN | Dir | S - Sale | $6.70 | -9,512 | 16.8K | -36% | -$63.7K | |
| D | 2022-01-18 | 2022-01-13 | VYGR | Voyager Therapeutics, Inc. | PIERCE GLENN | Interim CSO, Dir | A - Grant | $0.00 | +26.3K | 26.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations